Review
Nature Reviews Microbiology 6, 17-27 (January 2008) | doi:10.1038/nrmicro1818
There is an Erratum (November 2009) associated with this article.
The biology and future prospects of antivirulence therapies
Lynette Cegelski1, Garland R. Marshall2, Gary R. Eldridge3 & Scott J. Hultgren1 About the authors
Abstract
The emergence and increasing prevalence of bacterial strains that are resistant to available antibiotics demand the discovery of new therapeutic approaches. Targeting bacterial virulence is an alternative approach to antimicrobial therapy that offers promising opportunities to inhibit pathogenesis and its consequences without placing immediate life-or-death pressure on the target bacterium. Certain virulence factors have been shown to be potential targets for drug design and therapeutic intervention, whereas new insights are crucial for exploiting others. Targeting virulence represents a new paradigm to empower the clinician to prevent and treat infectious diseases.
- View At a Glance
Author affiliations
- Department of Molecular Microbiology, Washington University, Saint Louis, Missouri 63110, USA.
- Center for Computational Biology and Department of Biochemistry and Molecular Biophysics, Washington University, Saint Louis, Missouri 63110, USA.
- Sequoia Sciences, Saint Louis, Missouri 63114, USA.
Correspondence to: Scott J. Hultgren1 Email: hultgren@borcim.wustl.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Filming bacteriaNature Structural Biology News and Views (01 Nov 2003)
Microbiology Group effort in toxin synthesisNature News and Views (03 Jan 2002)
See all 3 matches for News And ViewsRESEARCH
Temporal changes in allele frequency, genetic variation and inbreeding depression in small populations of the guppy, Poecilia reticulataHeredity Original Article
Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formationNature Chemical Biology Article (01 Dec 2009)
See all 11 matches for Research
